510(k) K021194
K021194 is an FDA 510(k) premarket notification submitted by Hemagen Diagnostics, Inc. for the device "RAICHEM CRP HIGH SENSITIVITY TEST SYSTEM". The FDA issued a decision of Substantially Equivalent on July 29, 2002. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Hemagen Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 29, 2002
- Date Received
- April 15, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type